Godavari Drugs Ltd.

BSE: GODAVARI · Pharmaceuticals · sector

₹122.40BSE close 2026-10-26

Key numbers

Market cap₹92 cr

Price₹122.40

52w high / low₹144 / ₹70

P/E23.8xSector median 27.9x

P/B1.2xSector median 2.9x

Book value₹100.6

Dividend yield–Sector median 0.48%

ROE7.0%Sector median 11.7%

ROCE5.8%Sector median 12.3%

OPM9.3%Sector median 14.0%

Debt / equity1.01xSector median 0.16x

EV/EBITDA15.0xSector median 18.6x

Interest cover2.3x

Current ratio1.31x

Sales growth 3y-12.8%Sector median +9.6%

Profit growth 3y+2.6%Sector median +13.3%

PEG9.20x

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹15 cr vs borrowings ₹76 cr (FY26): borrowings are higher by ₹62 cr.
Operating profit covered interest 2.3x in the last 12 months.
Other income was 23% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹122.40 on 2026-10-26: -15.2% from the 52-week high, +75.6% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹140.00 · low ₹70.24

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	26	24	27	22	33	28
EBITDA	3	3	2	3	3	3
OPM %	12.2%	12.2%	7.5%	12.3%	9.2%	9.0%
Other income	0	0	1	0	0	0
Net profit	1	1	1	1	1	1
EPS (₹)	1.19	1.38	1.33	1.01	1.71	1.10
Revenue YoY					+30.0%	+17.4%
Profit YoY					+44.9%	+6.7%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	161	160	157	113	106	110
EBITDA	11	10	13	12	11	10
Net profit	5	4	6	4	4	4
EPS (₹)	6.97	5.03	7.37	5.82	5.43	5.15
Revenue growth		-0.9%	-1.8%	-27.7%	-6.7%	–
Profit growth		-27.8%	+46.4%	-21.1%	-6.6%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	-12.8%	–	–
Net profit	+2.6%	–	–
EPS	+2.6%	–	–
Share price	–	+1.3% (2y)	+51.4%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	43	76
Borrowings	62	76
Cash & equivalents	2	15
Total assets	143	200
Fixed assets	33	30
Capital work in progress	30	57
Investments	0	0
Receivables	42	44
Inventory	28	46
Payables	29	35

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	11	1
Cash from investing	-20	-26
Cash from financing	8	37
Capex	20	27
Free cash flow	-9	-26

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	10.1%	5.4%
ROCE %	9.9%	5.9%
Debtor days	136	150
Inventory days	125	217
Payable days	128	163
Cash conversion cycle (days)	133	204
Working capital days	18	92

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
GODAVARI	₹92 cr	23.8x	1.2x	7.0%	5.8%	9.3%	-12.8%	–

All 185 companies in Pharmaceuticals →

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	GODAVARI
BSE code	530317
ISIN	INE362C01012
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.